about
Cyclophosphamide, hydroxyurea, actinomycin D, methotrexate, and vincristine in the treatment of gestational trophoblastic neoplasia.20-year experience of managing profuse bleeding in gestational trophoblastic disease.Differentiation of aggressive and indolent subtypes of uterine sarcoma using maximum standardized uptake value.The role of laparoscopy in staging of different gynaecological cancers.Impact of different educational interventions on psychosocial well-being of women with a positive high-risk human papillomavirus and normal cervical cytology: a randomised trial.Robot-assisted gynaecological cancer surgery-complications and prevention.Patient compliance with cervical smear surveillance in a shared-care setting.Epigenetic alteration of the metallothionein 1E gene in human endometrial carcinomas.The mitosis-specific marker phosphohistone-H3 (PHH3) is an independent prognosticator in uterine smooth muscle tumours: an outcome-based study.HBsAg carrier status and the association between gestational diabetes with increased serum ferritin concentration in Chinese women.Maternal hepatitis B infection and gestational diabetes mellitus.A randomized trial to compare the use of sublingual misoprostol with or without an additional 1 week course for the management of first trimester silent miscarriage.Relationship between intravoxel incoherent motion diffusion-weighted MRI and dynamic contrast-enhanced MRI in tissue perfusion of cervical cancers.Impact of iASPP on chemoresistance through PLK1 and autophagy in ovarian clear cell carcinoma.Soluble E-cadherin promotes tumor angiogenesis and localizes to exosome surface.Oncogenic microRNA signature for early diagnosis of cervical intraepithelial neoplasia and cancerThe role of regular physical examination in the detection of ovarian cancer recurrenceSingle-dose methotrexate regimen in the treatment of low-risk gestational trophoblastic neoplasiaReversed diastolic flow in the middle cerebral artery: is it a terminal sign in a growth-retarded fetus?The impact of maternal HBsAg carrier status on pregnancy outcomes: a case-control studyFull karyotyping, rapid aneuploidy diagnosis or both when invasive prenatal testing is performed for diagnosis of thalassaemia?Gestational trophoblastic diseaseA Case Series of Five Patients With Pure or Mixed Gestational Epithelioid Trophoblastic Tumors and a Literature Review on Mixed TumorsThe Value of Contrast-Enhanced CT in the Detection of Residual Disease After Neo-Adjuvant Chemotherapy in Ovarian CancerNapsin A, Hepatocyte Nuclear Factor-1-Beta (HNF-1β), Estrogen and Progesterone Receptors Expression in Arias-Stella ReactionSuccessful Treatment of a Pararenal Pregnancy Using High-Dose Methotrexate Regimen: A Case ReportDiffusion-weighted magnetic resonance imaging of primary cervical cancer in the detection of sub-centimetre metastatic lymph nodesDiffusion Kurtosis Imaging in the Assessment of Cervical CarcinomaPredictive biomarkers and tumor microenvironment in female genital melanomas: a multi-institutional study of 55 casesPrimary HPV testing with cytology versus cytology alone in cervical screening-A prospective randomized controlled trial with two rounds of screening in a Chinese populationPlacental Site Trophoblastic Tumor: A Distinct Entity of Gestational Trophoblastic Disease Experience from a Tertiary Referral Center in Hong Kong
P50
Q33420029-8C9E02E6-A8C8-4A85-9A1F-DE5BC008077AQ36855057-AE6C4F12-0DD9-4F99-A747-E24437B201B0Q37273298-21F2E7E7-C9B6-404D-B956-2118C1AD99F8Q38394896-A830E5B3-9453-424B-89FF-D7BF4B579E09Q38845824-E80AF95D-4C95-4EFD-A116-C6819E8E565EQ39320784-459F43A0-15FB-4B28-B5CC-39C2599CA0F4Q39566432-24DC8A33-C368-46D3-BBE2-705C3A5D8708Q39855727-AF54A782-7CA4-4C3D-B2E7-5F2123C8250CQ40466987-9242AA0D-6300-4209-BE17-35A55E45E56BQ44631750-D8FA3B54-EDE8-4B1D-8071-E1FE410932ABQ45009566-99997D85-23AE-4B04-A641-C386CDBAB750Q46697004-4B2D987F-9DBF-454F-8F02-F8627FB5A72FQ51009634-B334762A-53A7-4E7A-B2C4-F74A74739A88Q54980892-1315A11F-8823-4DBB-A9F6-ED40BF18E168Q55196550-FE636B4A-1BD6-4D87-8132-40BD1F998E12Q57156406-BA010372-3219-4CE9-A6D2-2E298725F833Q57706096-4F3CBC3E-258F-448D-86B9-546F52F44683Q57706153-831E9090-1FA9-48E6-8512-2AFA9AD139CAQ73102689-8159159A-B875-4BB3-B8C1-E9A479A1CC03Q81156601-CC0A7390-05C0-43D2-856C-91AB9EA5D521Q82297526-1BF39F90-D7CA-448C-A69A-88BDD01665EEQ83347397-EC0B9FEA-B9B3-4E42-AF9D-7AB7E8A8B852Q89088033-83CFE81B-3BC2-4074-BD82-08F8D87E4826Q90820940-46451872-00B9-413A-8EE8-091CFE04DD47Q90876763-4F9503C9-9C29-4829-ABEE-A8931FD88CACQ91505583-FB7CFF02-8B9F-4C49-9915-7C1491620CCDQ91607317-58C67556-0B7A-4DEB-A7DB-1FCFEAE422F5Q92032926-08B22239-E404-49E1-92F7-962B4324FFA7Q92432380-90DA18BD-8D3D-4EAB-BD39-1AF451655831Q92545834-ED1BCFCB-8028-40B7-91D9-5507ED86AFC7Q92924802-6BD91DED-053D-48FE-AC5E-A7C05752E689
P50
description
researcher ORCID ID = 0000-0001-8330-0970
@en
name
Ka Yu Tse
@ast
Ka Yu Tse
@en
Ka Yu Tse
@nl
type
label
Ka Yu Tse
@ast
Ka Yu Tse
@en
Ka Yu Tse
@nl
prefLabel
Ka Yu Tse
@ast
Ka Yu Tse
@en
Ka Yu Tse
@nl
P31
P496
0000-0001-8330-0970